Antisense Oligonucletide (ASO)
13 Employers in 17 locations
13 Employers in 17 locations
Employers working on Antisense Oligonucletide (ASO) work in 23 other areas
Displaying 1 - 15 of 23 related areas- RNA (5)
- Biologics (2)
- Cell and Gene Therapy (2)
- COVID-19 (2)
- miRNA (2)
- Small Molecules (2)
- Therapeutics (2)
- Alzheimer's (1)
- Antibodies (1)
- Antisense RNA (1)
- Artificial Intelligence (1)
- Autoimmunity (1)
- Cancer (1)
- Cancer Therapeutics (1)
Displaying 1 - 13 of 13 employers
Only three business areas are listed for each employer.Business Area(s)
Description
AptamiR Therapeutics has created an innovative model of virtual and outsourced ...
Business Area(s)
Description
Biogen discovers, develops and manufactures therapies for serious neurological ...
Business Area(s)
Description
Creyon Bio is taking an engineering approach to creating new oligonucleotide ...
Business Area(s)
Description
Flamingo has a late-stage pipeline focused RNA-targeting antisense ...
Business Area(s)
Description
Gatehouse Bio is a biotechnology company focused on decoding small RNA (sRNA) to ...
Business Area(s)
Description
HAYA Therapeutics is a precision therapeutics company that discovers and ...
Business Area(s)
Description
Ionis makes antisense oligonucletides that target mRNA molecules that code for ...
Business Area(s)
Description
Judo Bio is pioneering oligonucleotide medicines delivered to the kidney ...
Business Area(s)
Description
Oncotelic is an immuno-oncology company dedicated to the development RNA ...
Business Area(s)
Description
PepGen uses their Enhanced Delivery Oligonucleotide technology to solve the ...
Business Area(s)
Description
Sarepta Therapeutics is a biopharmaceutical company focused on developing ...
Business Area(s)
Description
Stoke is developing antisense oligonucleotide medicines that target RNA splicing ...
Business Area(s)
Description
Switch’s Conditionally Activated siRNA (CASi), developed at Caltech, Harvard ...